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ABSTRACT: 
Hepatitis C is quickly becoming a national threat, involving 2% of the nation’s population, 
ranking this as the 11th most prevalent disease in the world.  Traditionally, treatment for hepatitis 
C has been conducted in tertiary care settings, limiting access to care for those residing in rural 
areas.  Improving access to care through the development of a Doctor of Nursing Practice (DNP) 
nurse-managed clinic in a rural setting will improve health outcomes and quality of life for those 
treated outside the traditional setting.  Caring for those living in less densely populated areas 
requires an understanding of rural culture. This paper will discuss the development and 
implementation of a DNP Model of Care for rural patients being treated for hepatitis C.  The 
model of care starts with identifying hepatitis C, treating the patient following established 
medical guidelines, using the nursing model to monitor clinical progress and managing side-
effects caused by the treatment medications. Using the DNP Model of Care, a patient-focused 
clinic can successfully treat rural patients utilizing the principles of the Effect Theory for 
management and the Process Theory for ongoing evaluation. Collaboration with other key 
resources, utilizing a multidisciplinary approach allows the DNP nurse to care for those requiring 
treatment for chronic hepatitis C, where they live and work with the assistance of family and 
social support. 
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The Institute of medicine (IOM) considers hepatitis C a major health problem and a 
major cause of liver disease.1 Approximately 4.1-4.9 million people are affected with hepatitis C 
(HCV) in the United States, accounting for 1.8-2.0% of the general population, 2,3,4resulting in 
8,000-10,000 deaths annually.5,8 Ranked as the 11th most prevalent disease in the world,6 there 
are 170 million cases of HCV responsible for 1.4 million deaths per year worldwide,3,4,5,6 but 
these numbers are difficult to obtain without a national hepatitis C surveillance program.1  These 
statistics are expected to triple in the next 10-20 years,8 positioning HCV as a “global epidemic” 
in the new millennium,9 even as it has been termed the next “hidden epidemic”.10   HCV is the 
most common blood-borne infection in the United States and is the leading cause of liver 
transplants.8,11,12,13  The Organ Procurement and Transplantation Network located in the U.S.,  
states that 6,320 patients underwent liver transplantation in 2009 for treatment of end-stage liver 
failure, with nearly 17,000 patients currently waiting for a donor liver.14  Approximately 75%-
85% of acutely infected individuals progress to chronic infection with up to 20% developing 
cirrhosis over 20-30 years, putting them at risk for end-stage liver disease and hepatocellular 
carcinoma (HCC) 4,15  and possible severe quality of life impairment.  The risk of HCC is 1%-4% 
per year when cirrhosis of the liver is present,13 and this is expected to increase over the next 
decade due to the slow progression of the disease.  HCC is the third leading cause of cancer 
deaths in the worldwide, the fifth most common cancer among men and the eight most common 
cancer among women.14   Antiviral therapy is considered standard of care even when eradication 
of the virus may not occur, as it reduces the risk of developing malignancy.15Because of routine 
screening of blood products, the number of new HCV cases is declining, but the rates of HCV 
associated morbidity and mortality will continue to rise4 for the next  20-30 years.  Though the 
incidence of acute and chronic hepatitis A and B are diminishing in this country, and 
theoretically eradication of these diseases could occur over the next 20 years through standard 
  
vaccination, HCV has multiple types and subspecies with a high rate of mutation, making 
vaccine development very difficult.  Until a vaccine is developed, reducing the spread of the 
HCV needs to be continued though the identification of risk factors.  
 
Rural Nursing and Quality of Life 
Rural Nursing poses challenges and opportunities for unique care and is different from 
urban nursing due the essentials attributes and culture of this population. This nursing has been 
identified as providing health care by professional nurses to persons living in sparsely populated 
areas,16 though these areas are not well defined.   Rural can mean country, agriculture, or just in 
terms of assumed culture.  Sparsely populated can be defined anywhere between 3 and 1,000 
persons per square mile.  DNP nurses working in any setting require a model of care with a 
theory base by which to practice and rural nursing is no exception.  Once diagnosed with HCV, 
rural patients may not start treatment due to inconvenient access to specialist care,17 which is 
traditionally available in tertiary care settings located in urban areas.  Rural health care providers 
are expected to do more with less and accept responsibilities not usually seen by providers in the 
urban setting.  Health and work beliefs, isolation, distance, outsider/insider concept, self-
reliance, and lack of anonymity of familiarity are concepts identified with the rural community.18 
Lack of health accessibility is a major factor with the rural patient.  Transportation, distance, 
isolation, weather, finances, time of year (including planting and harvesting of crops, and 
hunting season), attitudes toward health and patient education may be barriers to care and all 
must be considered before hepatitis treatment is considered.19   Seasonal agricultural farm 
workers who are transient and are of a different culture may be included as a subset population.  
Understanding these concepts of rural nursing will require the DNP to create an evidence-based 
plan of care for the HCV patient undergoing treatment. 
  
Side effects experienced by patients may be minimal or quite severe.  The most common 
reason to discontinue treatment is psychiatric side-effects such as depression, 20 suicidal and 
homicidal thoughts.  “Road rage” has been seen in some patients.  Rural areas may few mental 
health clinics, thus primary care providers may be the only source of care.  Keeping the primary 
care provider aware of treatment any psychiatric concerns early in treatment may avoid disaster 
from side effects.  Do not hesitate to discuss with the collaborating hepatologist and discontinue 
treatment if necessary. 
 
Theoretical Framework 
Nursing case management, provided by public health nurses and social workers, has been 
in practice since the 1800’s to improve health care to immigrants and those who could not afford 
health care.  Nursing clinics that include APN’s offer services to the uninsured and underserved 
that have chronic illnesses.  The DNP with advanced preparation will add diagnostic skills and, 
clinical management to those with chronic illness and in need of patient-focused care.  The 
Doctor of Nursing Practice Model of Care focuses on the patient, allowing the DNP to oversee 
the hepatitis C treatment while managing response to treatment and monitoring any side effects 
of care.  The office visits, laboratory monitoring and documentation by both the patient and 
managing nurse allow improved compliance and success rates in treatment.  Critical thinking and 
decision making by APN’s are made with evidence-based information and a theoretical base.   
The Effect Theory brings together scientific facts and behaviors to deliver interventions and 
predict outcomes.21   This theory demonstrates a relationship between behavioral factors, disease 
causality, with moderating and mediating mechanisms, and disease treatment outcomes. The 
identification of risk factors as described by the model will allow an accurate testing of possible 
disease and prediction of outcomes. 22  The theoretical framework used to implement this model 
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of care for the treatment of HCV is the Effect Theory, see Figure 1.  This combination theory 
provides the reader with an understanding of the complexity of HCV in the rural setting and its 
impact for treatment outcomes.  The DNP nurse practicing in a rural setting can best understand 
the needs of the HCV patient as this is where the patient is living and where primary intervention 
occurs.  The DNP also appreciates the cultural complexities of the rural setting. (Figure 1.) 
Figure 1. The Effect Theory  
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Flow Chart showing how HCV can be used in an Effect Theory using a linear chart. 
Adapted from “Health Program: Planning and Evaluation: A Practical Systematic Approach for 
Community Health,” by L. M. Issel, 2009, pg. 181.  
 
DNP Model of Care for a Rural Clinic 
Although traditional treatment for hepatitis C is carried out in tertiary/hospital settings, a 
rural clinic managed by a Doctor of Nursing Practice nurse, working in collaboration with a 
hepatologist, can successfully evaluate and manage the multiple complications and side effects 
commonly seen with hepatitis C treatment.  Patient-centered availability, access to treatment 
with cost savings benefits seen by nurse-managed clinics,23 allows a rural clinic for hepatitis C 
an acceptable option for viral treatment.  Below (Figure 2.) is the DNP Model of Care developed 
by the author for those with chronic illness in a rural setting and used for the patient being treated 
with hepatitis C.  The patient is the focus of care with the DNP surrounding the outer circle of 
the model as the manager of the care.  Surrounding the patient are factors that influence 
treatment outcomes, such as quality of life or completion of treatment, and failure to eradicate 
the virus.  In a rural setting the complicating factors for the patient will be different than care 
within an urban setting, thus it is necessary to incorporate these into the surrounding boxes the 
individual factors that may complicate treatment. (Figure 2.) 
 
 
 
 
 
  
Figure 2. Krebbeks Doctor of Nursing Practice Model of Care 
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A mission statement needs to be made for any clinic development.  This should state the 
purpose of the clinic, how I will be developed and how it will be evaluated.21 Clinical Objectives 
also need to be established for a DNP managed HCV clinic.  These include: 
• To increase awareness for the prevention of HCV to prevent new infections 
• To target lifestyle changes needed with HCV treatment 
• To improve access to HCV treatment 
• To provide services to those uninsured and underinsured 
• To provide a shorter time from diagnosis to treatment 
• To reduce the impact on health costs for treatment 
• To prevent the complications for cirrhosis associated with HCV 
  
• To obtain a sustained virological response early in treatment and 6 months 
following completion of treatment 
Once the mission statement and objectives for the clinic have been established, 
implementing the plan of care for the patient with HCV will be followed using the guidelines of 
the model of care and the theoretical framework which is consistent with the program purpose 
and objectives. The patient is referred to the clinic from their primary care provider, OB/GYN or 
from recent incarceration. On the first visit, the patient enters the clinic  with a definite diagnosis 
for HCV or may be referred to the clinic with abnormal liver function tests.  The DNP will either 
establish the diagnosis of HCV or confirm the presence of chronic active HCV through the 
identification of active virus with a RNA quantitative viral load and genotyping of the virus.  
Supplemental baseline laboratory testing is done at this first visit.  These tests include a CBC, 
chemistries, autoimmune and viral indices (HAV and HBV), ferritin level, TSH, HIV and HCG 
for female patients and for partners of male patients if they are of child-bearing age.  An 
abdominal ultrasound is obtained on all patients to observe the contour of the liver.  This may 
give the DNP an indication if cirrhosis is already present.  If any question exists, then an 
ultrasound guided liver biopsy may be obtained, but mandatory liver biopsy is no longer 
necessary prior to treatment.7   An informational packet is given to the patient at this first visit.  
These packets contain information on the treatment drugs including how they are used with side 
effects and cautions regarding their use.  These drugs have a “black box warning”, meaning they 
may have dangerous side effects under certain circumstances.  It is important not to overwhelm 
the patient at this point as they have received an extreme amount of information on this first visit.  
Allowing an hour of time for this visit is not unusual.   
  
The second visit is about 2-3 weeks later, allowing the results of all testing done to this 
point to return.  The DNP will review all the previous testing including the result of the viral 
quantitative count.  If confirmation of HCV is determined with a positive number, then a more 
detailed discussion regarding the treatment is made.  The patient is given a journal for recording 
laboratory results, documenting exercise/physical activity done,24  and any questions or concerns 
they may have.  A patient/provider contract for treatment is reviewed and signed by both parties.  
This contract contains patient responsibilities, including appointment visits, laboratory times, and 
the importance of alcohol abstinence and the use of non-prescribed drugs.  Of significance 
importance is the understanding of not becoming pregnant or impregnating anyone else, as 
treatment drugs for HCV are teratogenic.  A dilated fundoscopic eye exam is important at the 
beginning of treatment to determine any baseline abnormalities, as some abnormalities rarely 
occur as a result of the treatment drugs bur usually subside after treatment completion.  An 
influenza immunization is recommended during the season and vaccination for HAV and HBV 
are important if the patient has not had established immunity.  Avoiding exposure to and 
combating these other hepatitis viruses during treatment may be difficult.  
Regular office visits occur at 1,2,4,6,8,12 and every 4 weeks thereafter until treatment is 
completed.  Laboratory testing is obtained at these times to assure no serious consequences are 
occurring.  Calculating and documenting serial absolute neutrophil counts (ANC) is important 
when monitoring for serious side effects.  Following medical protocol regarding these values is 
essential.  It is important to obtain a quantitative viral load at weeks 4,12,24,36, and 48, then 1, 3, 
and 6 months post-treatment.  Testing yearly thereafter has not been established.  The patient is 
weighed at each visit to monitor any loss.  Some weight loss is expected but should not be 
excessive. 25  
  
Treatment and Screening for Hepatitis C 
The standard treatment of care for HCV is well-documented by the American 
Gastroenterological Association (AGA),  American Association for the Study of Liver Diseases 
(AASLD) and the New York State Department of Health (NYSDOH),11,12,26  which needs to be 
followed by the DNP.  Any deviation from those protocols needs to be discussed with the 
collaborating physician first.  
It is important for the patient to know how to administer these medications.  The start of 
treatment begins in the clinic office.  The DNP or clinic nurse shows the patient how to 
administer the medications with an emphasis on technique and hygiene.  Safe disposal of the 
used needles and syringes is essential for safety of the patient and any household members. 
The baseline eye exam and subsequent exams during treatment are at the discretion of the 
ophthalmologist performing the initial exam, and are important to follow any cotton-wool 
exudates.  Retinopathy is common with pegylated interferon, one of the treatment medications, 
but most events clear after treatment is completed.27   The cost of treatment with pegylated 
interferon and ribavirin is very high, about $30,000 per patient for the medication alone.2  The 
National Surveillance Program calculated the cost of screening for HCV to be $1,246 per case 
detected, though other studies have shown the cost between $374 and $1.047 per case detected.8  
HCV screening and early treatment has the potential to improve average life-expectancy but 
should focus only on those at high risk for the virus,28 as screening those without risk factors has 
not been proven to be cost-effective.  Approximately 30% of patients identified with chronic 
HCV have normal liver tests but upon liver biopsy, have some degree of liver damage, thus it 
remains very important to screen for those with current or past risk behavior for the virus.14 
  
The future treatment for HCV will soon change.  The addition of protease inhibitors are 
currently being evaluated by the Federal Drug Administration (FDA) and will be added to 
standard treatment, but their exact role is yet to be determined.29   The identification of genetic 
variations with response to treatment may also influence viral eradication.30  These changes are 
expected to occur mid to late 2011.  The large tertiary clinics should be able to incorporate these 
changes with little difficulty, but the rural areas may find resources and funding difficult to 
manage.  Despite this, the management of HCV treatment in a rural setting should be reasonable 
with a workable model of care and a collaborating health team. 
Evaluation Plan 
Evaluating this model of nursing care needs to include both quantitative and qualitative 
outcomes.  Mentioned previously are quality of life concerns regarding HCV.  Observation by 
the DNP during office visits, conversation with patients and families with review of journal 
entries are all forms of qualitative measurements.  Quantitative measurements may include 
compliance with office appointments, medication adherence and successful eradication of the 
virus at completion of the treatment contract.  Some of these measurements can be seen through 
the monitoring of laboratory values, the expected depletion of medication, acceptable with 
changes and lack of legal involvement. 
Clinical conferences with collaborators involved in those patients undergoing HCV 
treatment will be essential for the success of the clinic.  Effective leadership by the DNP 
manager will require a strong support staff with those wanting to make a difference, the creation 
of ideas and actions, creativity with energetic and committed followers.31  This author advocates 
a “circle network” that allows and encourages information to move from one member to another 
equally.  Communication is simplified and members have easy access to other member’s 
  
thoughts32   and team members share responsibility for achieving the common goals of the 
clinic.33  Familiarity among staff members of the clinic is also important for the patients.  With a 
small group in a rural setting, this management structure should be very effective. 
An evaluation plan of the program must include operating costs of the clinic.  One 
method to do this uses the break-even analysis tool.  This mathematical calculation divides the 
fixed cost of operation of the clinic into the cost per patient equaling the number of patients 
needed to be seen.21  This analysis should be done before the operational of the clinic begins, 
early in its operation and throughout its management.  Unfortunately, lack of health insurance 
can be a critical factor in treating this potentially vulnerable population.  Medicare and Medicaid 
can underestimate actual costs for providing services which can greatly affect operational costs.  
If patients have no health insurance, it is essential for them to apply for financial assistance for 
both their advantage and for the security of the clinic.  At one point a potential solution for those 
looking to start an independent, rural clinic was H.R. 2754, to amend the Public Health Service 
Act to establish the Nurse-Managed Health Clinic Investment Program, and other purposes, may 
have be an option,34 but unfortunately the bill did not become a law, but may be presented again 
with the next session of Congress.  Another solution is to incorporate the nurse-managed clinic 
into an existing gastroenterology or primary care practice to help defray the costs.  Sharing of 
office equipment and staff with the DNP providing care to those with HCV along with patients 
with other health problems may need to be done until the clinic is financially secure.  A third 
method to provide cost-effective care is the use of telemedicine. Its use in rural and prison 
settings allows providers to effectively manage patients with chronic illness.35 The Process 
Theory showing the components of the organizational and service plans may be used for a nurse-
managed clinic as shown below. (Figure 3.)  
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Figure 3. The Process Theory, Evaluation Flow Chart 
 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Flow chart showing how a logic model as a tool for program evaluation may be used for 
HCV.  Adapted from “Health Program” Planning and Evaluation: A Practical Systematic 
Approach for Comminity Health”, by Issel, LM. 2009, pg. 276. 
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Conclusion 
As health care becomes more complex, evidence-based practice with collaboration 
among multiple health disciplines needs to be implemented.  Cost effective care with positive 
outcomes and individualized care with innovation will be necessary.  The IOM suggests 
knowledge about this disease is poor1 and significant stigma surrounds the diagnosis.36 With an 
accepted and useful model of care, theoretical framework with an ongoing evaluation tool, a 
hepatitis C clinic within a rural setting can be successfully managed by a DNP prepared nurse.  
Using the Effect and Process Theory, with the DNP Model of Care, patients with HCV can be 
provided quality, culturally sensitive and cost-effective care. With the IOM’s concern regarding 
the spread of HCV and Healthy People 2020 including communicable disease a national concern, 
a DNP nurse-managed clinic can fill the gap and meet the need for addressing this “global 
epidemic”. 
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Figure 2. Krebbeks Doctor of Nursing Practice Model of Care 
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Informational System 
Monthly/Weekly reports of intake 
and outputs 
 
 
Budget 
break-even analysis 
 
 
Time line 
Anticipated start date 7/1/11 
 
Organizational chart 
Circle Network 
DNP/MD 
MT/Receptionist 
(Bolman & Deal, pg 106) 
Operational Manual 
Office Protocol 
visit times/freq/vital signs, flow 
chart, patient log 
 
  Outputs 
 
Services 
utilization plan 
 
 
Participants 
Those patients with positive 
antibody or active HCV virus 
requiring tx or monitoring of 
virus 
 
Queuing 
Increase testing for HCV virus 
Info PCP's 
Decrease wait list time to 2 
weeks and start of tx 
 
Intervention Delivery 
NYSDOH Guidelines 2005 
with 
collaborating MD with constant 
update as tx changes 
 
Outputs 
 
Coverage 
Ins 
Private pay, sliding fees 
Indigent Coverage from 
drug manufacturer 
 
Units of Service 
Frequency of Lab testing, 
Number of Visits 
Length of Treatment 
(Patient flow sheet) 
 
Work Flow 
# of pts seen 
Need for regular staff meetings 
Staff education 
 
Materials produced 
Number of pts in tx 
Continued and completed tx 
Number of pts with SVR 
 
Figure 3. The Process Theory, Evaluation Flow Chart 
 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Organizational 
plan input 
 
Human resources  
DNP 
 Med tech  
Collaborating MD  
Receptionist 
 
Informational resources 
Software for EMR (existing) 
Educational handouts/Roche pt 
journals 
 
 
Monetary  resources 
Grant Application (if nec) 
 
 
Physical Resources 
Pre-existing Office, needing two 
exam rooms and reception area 
 
Transportation 
Private Car 
CATS bus 
VAMC transport 
 
Time resources 
1 and 2 year cycles 
 
 
Managerial resources 
DNP clinic manager 
 
Social marketing 
Product-treatment 
Price-ins coverage 
Place-exist office 
Promotion-posters/speaking 
 
 
 
  
